Study to Evaluate the Efficacy and Safety of ATNC-MDD V1(TMS With Cognitive Training) in Mild Alzheimer's Dementia
RecruitingNCT06088121Phase: NAStarted 2023-05-15
Summary
The study tests the effect of the ATNC MDD-V1 on Alzheimer patients' cognitive function. The ATNC MDD-V1 uses non-invasive stimulation of both magnetic and cognitive training.
Eligibility
Sex
ALL
Min Age
60 Years
Max Age
85 Years
Locations
Catholic university of Korea Incheon St. Mary's HospitalIncheon, Bupyeong 6(yuk)-dong, Bupyeong-gu, South Korea
Chung-Ang University Gwangmyeong HospitalGwangmyeong, Deokan-ro 110, South Korea
jeonbuk National University HospitalJeonju, Deokjin-gu, South Korea
Chonnam National University HopitalGwangju, Dong-gu, South Korea
Yeungnam University Medical CenterDaegu, Hyeonchung-ro, Nam-gu, South Korea
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT06088121